Neurodegenerative diseases: pathogenic mechanisms

Group leader

Manuel Guzmán Pastor

mguzman(ELIMINAR)@quim.ucm.es

Tlf. 0034 91 394 46 68

Principal Investigators

  • Ismael Galve Roperh
  • Javier Palazuelos Diego

Collaborators

  • Cristina Blázquez Ortiz
  • Javier Díaz Alonso
  • Daniel García Rincón
  • Elena García Taboada
  • Juan Paraíso Luna
  • Eva Resel Mariné
  • Andrea Ruiz Calvo
  • Adán de Salas Quiroga
  • José Aguareles Gorines
  • Irene Maroto Martínez
  • Carlos Costas Insua
  • Alba Huerga Gomez
  • Tania Aguado Sánchez
  • Samuel Simón Sánchez
Imagen equipo

Group leader

Manuel Guzmán Pastor

mguzman(ELIMINAR)@quim.ucm.es

Tlf. 0034 91 394 46 68

Principal Investigators

  • Ismael Galve Roperh
  • Javier Palazuelos Diego

Collaborators

  • Cristina Blázquez Ortiz
  • Javier Díaz Alonso
  • Daniel García Rincón
  • Elena García Taboada
  • Juan Paraíso Luna
  • Eva Resel Mariné
  • Andrea Ruiz Calvo
  • Adán de Salas Quiroga
  • José Aguareles Gorines
  • Irene Maroto Martínez
  • Carlos Costas Insua
  • Alba Huerga Gomez
  • Tania Aguado Sánchez
  • Samuel Simón Sánchez

STRATEGIC OBJECTIVES

The overall objective of our research is the study of the molecular mechanisms whereby the cannabinoid receptors act in the brain, as well as the validity of these receptors as therapeutic targets in neurodegeneration, neurorepair and neuro-oncology. Our work enables the characterisation of new mechanisms of action and cannabinoid receptor-mediated effects, and the identification of new physiopathological implications derived therein.

RESEARCH LINES

  • Neurogenesis and neurorepair by cannabinoid receptors.
  • Neuroprotection by cannabinoid receptors.

Location

Madrid Complutense University


Faculty of Biological Sciences
Annex Building
Department of Molecular Biochemistry and Biology
Calle José Antonio Novais, 12
28040 Madrid
0034 91 394 4668

Link to UCM group

Keywords

neurodegeneration, neurogenesis, neurorepair, neuropharmacology, cannabinoid